Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Birnie, W. Sauer, F. Bogun, J. Cooper, D. Culver, C. Duvernoy, M. Judson, J. Kron, D. Mehta, J. Nielsen, Amit Patel, T. Ohe, P. Raatikainen, K. Soejima (2014)
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.Heart rhythm, 11 7
Zeppenfeld (2022)
3997Eur Heart J, 43
(2017)
Abstracts of the Annual Spring Meeting 2017 of the European Congenital Heart Surgeons Association, Leicester, UK, 19-20th May, 2017Cardiology in the Young, 27
L. Alghothani, E. Crouser (2014)
Management of Cardiac Sarcoidosis
(2016)
Cardiac sarcoid- osis—state of the art review
H. Parikka (2018)
2018 ESC Guidelines for the diagnosis and management of syncope.Revista espanola de cardiologia, 71 10
N. Gilotra, D. Okada, Apurva Sharma, J. Chrispin (2020)
Management of Cardiac Sarcoidosis in 2020Arrhythmia & Electrophysiology Review, 9
(2005)
Cardiovascular magnetic resonance in cardiac amyl-oidosis
Tan (2019)
513Am J Cardiol, 123
R. Kandolin, J. Lehtonen, J. Airaksinen, T. Vihinen, H. Miettinen, K. Ylitalo, K. Kaikkonen, S. Tuohinen, Petri Haataja, T. Kerola, J. Kokkonen, Markus Pelkonen, Päivi Pietilä-Effati, Seppo Utrianen, M. Kupari (2015)
Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.Circulation
(2021)
Hereditary transthyretin amyloidosis: synonyms: familial amyloid polyneurop- athy, familial transthyretin amyloidosis, hereditary ATTR amyloidosis
Hulten (2016)
50Cardiovasc Diagn Ther, 6
Maceira (2005)
186Circulation, 111
J. Galuszka, Karel Vykoupil, M. Táborský (2019)
Practical conclusions from the new 2018 ESC Guidelines for the diagnosis and management of syncopeMedicína pro praxi
H. Fleming (1986)
Cardiac sarcoidosis.Clinics in dermatology, 4 4
Brignole (2018)
1883Eur Heart J, 39
K Zeppenfeld, J Tfelt-Hansen, M de Riva, BG Winkel, ER Behr, NA Blom, P Charron, D Corrado, N Dagres, C de, C hillou, L Eckardt, T Friede, KH Haugaa, M Hocini, PD Lambiase, E Marijon, JL Merino, P Peichl, SG Priori, T Reichlin, J Schulz-Menger, C Sticherling, S Tzeis, A Verstrael, M Volterrani (2022)
ESC Scientific Document Group. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC), 43
BackgroundSarcoidosis is a rare multiorgan inflammatory disorder of unknown aetiology, characterized by the formation of non-caseating granulomas in the affected organs. Cardiac involvement is underrecognized and observed in up to 25% of cases in autopsy studies, and is associated with a high mortality rate, especially due to sudden cardiac death due to ventricular arrhythmias.Case summaryA 41-year-old man well known to our hospital because of his father’s diagnosis of cardiac amyloidosis, and carrier of transthyretin (TTR) gene mutation, was hospitalized following a resuscitated cardiac arrest. The patient was hospitalized a month before for a syncopal episode with demonstration of preserved left ventricular ejection fraction (LVEF) with akinetic basal septum at heart ultrasound and normal coronary. Chest computed tomography, performed in the emergency department, was significant for hilar lymphadenopathies and pulmonary nodules highly suggestive of sarcoidosis. A subsequent 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) showed multiorgan phlogistic involvement, including the myocardium. After the diagnosis of cardiac sarcoidosis, the patient was started on steroids therapy and underwent ICD implantation. A follow-up 18-FDG-PET showed a reduction of organs glucose uptake and a follow-up echo an improvement in LVEF. Despite that, he occurs occasional recording of repetitive ventricular arrhythmias and one appropriate ICD shock during the next 12 months.DiscussionCardiac sarcoidosis is an insidious disease. Its diagnosis can be challenging, with no specific finding in echocardiography. The best strategy would be multi-modality imaging involving both magnetic resonance imaging with late gadolinium enhancement and 18-FDG-PET, followed by biopsy to confirm the diagnosis. Multi-modality imaging should be further used to evaluate the response to treatment and assess prognosis. Since the patient was a known carrier of the TTR gene mutation, many efforts were made in order to come up with the correct diagnosis considering that both cardiac amyloidosis and cardiac sarcoidosis are non-ischaemic cardiomyopathy with systemic involvement.
European Heart Journal - Case Reports – Oxford University Press
Published: Feb 7, 2023
Keywords: Cardiac sarcoidosis; Significant ventricular arrhythmias; Sudden death; TTR mutation carrier; Cardiac magnetic resonance imaging; Case report
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.